← Oncology Approval Tracker

FDA DECISION ·

Bortezomib Injection (Accord)

bortezomib · Accord Healthcare

FDA approvalNew formulationMultiple myeloma and mantle cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Additional bortezomib injection product approved for adults with multiple myeloma or mantle cell lymphoma.

LAMPGEN ANALYSIS

Why it matters

The approval adds a specific presentation of the established proteasome inhibitor.

What research teams should watch

Verify product concentration, permitted route, and preparation before substitution in an order set.

PRIMARY RECORDS

Sources